Divestment
Skyline Diagnostics
Skyline Diagnostics developed the AMLprofiler test to identify AML subtypes and support personalized cancer treatment decisions.
Key Facts
- Sector
Life Sciences
- Country
Netherlands
- Fund
LSP 3
- Entry
2009
- Exit
2012
Do You Want to Know More?
We are eager to explore how we can achieve great things together.
